Aroon Supramaniam

Southport, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation.

Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation.

Journal: Drug delivery and translational research

Published: July 09, 2025

Extracellular Vesicles Loaded with Long Antisense RNAs Repress Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Extracellular Vesicles Loaded with Long Antisense RNAs Repress Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Journal: Nucleic acid therapeutics

Published: March 26, 2024

ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection.

ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection.

Journal: International journal of nanomedicine

Published: October 23, 2023

An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.

An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.

Journal: Antiviral research

Published: September 24, 2023

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection.

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: August 25, 2022

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants.

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants.

Journal: Frontiers in immunology

Published: April 22, 2022

Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccine.

Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccine.

Journal: Science advances

Published: October 29, 2021

Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2.

Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2.

Journal: Molecular therapy. Methods & clinical development

Published: September 07, 2021

RNA-based gene targeting therapies for human papillomavirus driven cancers.

RNA-based gene targeting therapies for human papillomavirus driven cancers.

Journal: Cancer letters

Published: August 19, 2021

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.

Journal: bioRxiv : the preprint server for biology

Published: April 28, 2021

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 14, 2021

PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice.

PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice.

Journal: PloS one

Published: February 05, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026